Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Muscle Wasting Disorders Global Market Report 2025
Request Sample Buy Now
Global Muscle Wasting Disorders Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Muscle Wasting Disorders Global Market Report 2025

By Treatment Type (Medications, Physical Therapy, Nutritional Therapy, Surgery, Gene Therapy, Other Treatment Types), By Disorder Type (Muscular Dystrophy, Amyotrophic Lateral Sclerosis (ALS), Other Disorder Types), By End-User (Hospitals, Rehab Centers, Specialty Clinics, Other End-Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Muscle Wasting Disorders Market Overview

• Muscle Wasting Disorders market size has reached to $15.06 billion in 2024

• Expected to grow to $29.52 billion in 2029 at a compound annual growth rate (CAGR) of 14%

• Growth Driver: Sedentary Lifestyle Trends Fueling Growth In The Muscle Wasting Disorders Market

• Market Trend: Innovative Advancements In The Muscle Wasting Disorders Market

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Muscle Wasting Disorders Market?

Muscle wasting disorders, or muscle atrophy or muscle wasting, refer to a condition characterized by a diverse group of conditions that cause the progressive loss of muscle mass and strength. This can occur as a result of various factors, including disuse, aging, malnutrition, neurodegenerative diseases, and certain medical conditions.

The main treatments of muscle wasting disorders are medications, physical therapy, nutritional therapy, surgery, gene therapy, and others. Muscle wasting disorder medications refer to drugs that are used to treat conditions such as sarcopenia, cachexia, and muscular dystrophy. These medications aim to increase muscle mass and improve muscle function. They are used for the treatment of muscular dystrophy, amyotrophic lateral sclerosis (ALS), and others by hospitals, rehab centers, specialty clinics, and other end-users.

Muscle Wasting Disorders Market Size and growth rate 2025 to 2029: Graph

What Is The Muscle Wasting Disorders Market Size 2025 And Growth Rate?

The muscle wasting disorders market size has grown rapidly in recent years. It will grow from $15.06 billion in 2024 to $17.49 billion in 2025 at a compound annual growth rate (CAGR) of 16.1%. The growth in the historic period can be attributed to increasing aging population, rising incidence of chronic diseases, advancements in research and development, increased awareness of early diagnosis, emerging therapeutic approaches.

What Is The Muscle Wasting Disorders Market Growth Forecast?

The muscle wasting disorders market size is expected to see rapid growth in the next few years. It will grow to $29.52 billion in 2029 at a compound annual growth rate (CAGR) of 14.0%. The growth in the forecast period can be attributed to regulatory support, patient advocacy initiatives, healthcare infrastructure development, globalization of clinical trials, personalized medicine approaches. Major trends in the forecast period include telemedicine adoption, technological advancements in diagnostics, product innovation, collaborations and partnerships, advancements in therapeutics, research on molecular mechanisms, biopharmaceutical innovation.

The forecast of 14.0% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. neuromuscular clinics by driving up the cost of myostatin inhibitors and electrical stimulation devices sourced from Switzerland and Japan, exacerbating functional decline in patients and raising rare disease care expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Muscle Wasting Disorders Market Segmented?

1) By Treatment Type: Medications, Physical Therapy, Nutritional Therapy, Surgery, Gene Therapy, Other Treatment Types

2) By Disorder Type: Muscular Dystrophy, Amyotrophic Lateral Sclerosis (ALS), Other Disorder Types

3) By End-User: Hospitals, Rehab Centers, Specialty Clinics, Other End-Users

Subsegments:

1) By Medications: Anabolic Steroids, Hormonal Treatments, Anti-Inflammatory Drugs, Immunomodulatory Agents

2) By Physical Therapy: Resistance Training, Stretching Exercises, Aerobic Conditioning, Rehabilitation Programs

3) By Nutritional Therapy: protein supplements, Nutritional Counseling, Dietary Modifications, Micronutrient Supplements

4) By Surgery: Surgical Interventions For Muscle Repair, Orthopedic Surgeries, Procedures For Underlying Conditions

5) By Gene Therapy: Gene Replacement Therapy, CRISPR-Based Approaches, RNA Interference Techniques

6) By Other Treatment Types: Complementary Therapies, Psychological Support, Assistive Devices

What Is Driving The Muscle Wasting Disorders Market? Sedentary Lifestyle Trends Fueling Growth In The Muscle Wasting Disorders Market

Rising adherence to a sedentary lifestyle is expected to propel the growth of the muscle wasting disorders market going forward. A sedentary lifestyle refers to a lifestyle in which an individual is physically inactive and engages in little or no physical movement or exercise. Sedentary behavior can negatively impact muscle function, leading to a decline in muscle strength and endurance, contributing to muscle wasting disorders, and making IT more difficult for individuals to maintain their muscle mass and function. For instance, in 2022, according to the World Health Organization, a Switzerland-based intergovernmental organization, over 80% of adolescents and 27% of adults did not adhere to the physical activity levels recommended by the World Health Organization. Therefore, rising adherence to a sedentary lifestyle is driving the growth of the muscle wasting disorders industry.

Who Are The Major Players In The Global Muscle Wasting Disorders Market?

Major companies operating in the muscle wasting disorders market report are Pfizer Inc., F. Hoffmann-La Roche Ltd., Roche Holding AG, Novartis AG, Sanofi, GlaxoSmithKline (GSK), Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals, Acceleron Pharma Inc., Biogen Inc., Santhera Pharmaceuticals Holding AG, Mitsubishi Tanabe Pharma, Nippon Shinyaku Co. Ltd. (NS Pharma, Inc.), Sarepta Therapeutics Inc., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Axogen, Inc., FibroGen Inc., Cytokinetics Incorporated, Italfarmaco S.p.A., Scholar Rock, Bellerophon Therapeutics, Akashi Therapeutics, aTyr Pharma, Metabolic Solutions Development Company, Synaptogenix, MyoKardia, Inc., MyoTherix Inc.

What Are The Key Trends Of The Global Muscle Wasting Disorders Market? Innovative Advancements In The Muscle Wasting Disorders Market

Major companies operating in the muscle wasting disorders market are developing innovative products, such as novel gene therapy, to better serve patients with muscle wasting disorders. Novel gene therapy refers to a medical technology that aims to produce a therapeutic effect through the manipulation of gene expression or altering the biological properties of living cells. For instance, in June 2023, Sarepta Therapeutics, a US-based biotechnology company, introduced Elevidys, which is the first gene therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Duchenne muscular dystrophy (DMD) in pediatric patients between the ages of 4 and 5 years old. Elevidys is a recombinant gene therapy designed to deliver into the body a gene that leads to a shortened protein that contains selected domains of the dystrophin protein of normal muscle cells. The product is administered as a single intravenous infusion.

Need data on a specific region in this market?
Request Customisation

What Are Latest Mergers And Acquisitions In The Muscle Wasting Disorders Market? Biogen Expands Rare Disease Portfolio through Acquisition of Reata Pharmaceuticals

In September 2023, Biogen Inc., a US-based biotechnology company, acquired Reata Pharmaceuticals Inc. for $7.3 billion. With the acquisition, Biogen is expected to bolster Biogen's rare disease portfolio with the addition of Friedreich's ataxia, which is a genetic, progressive, life-shortening, debilitating, and degenerative disease that affects the nervous system and muscles. Reata Pharmaceuticals Inc. is a US-based pharmaceutical company focused on developing therapeutics for neuromuscular disorders and muscle wasting disorders.

What Is The Regional Outlook For The Global Muscle Wasting Disorders Market?

North America was the largest region in the muscle wasting disorder market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Muscle Wasting Disorders Market?

The muscle wasting disorders market consists of revenues earned by entities by providing services such as diagnostic services, medical services, support services and community services. The market value includes the value of related goods sold by the service provider or included within the service offering. The muscle wasting disorders market also includes sales of anabolic steroids, growth hormone, enobosarm and bimagrumab. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Muscle Wasting Disorders Industry?

The muscle wasting disorders market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the muscle wasting disorders industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Muscle Wasting Disorders Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $17.49 billion
Revenue Forecast In 2034 $29.52 billion
Growth Rate CAGR of 14% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Treatment Type: Medications, Physical Therapy, Nutritional Therapy, Surgery, Gene Therapy, Other Treatment Types
2) By Disorder Type: Muscular Dystrophy, Amyotrophic Lateral Sclerosis (ALS), Other Disorder Types
3) By End-User: Hospitals, Rehab Centers, Specialty Clinics, Other End-Users Subsegments: 1) By Medications: Anabolic Steroids, Hormonal Treatments, Anti-Inflammatory Drugs, Immunomodulatory Agents
2) By Physical Therapy: Resistance Training, Stretching Exercises, Aerobic Conditioning, Rehabilitation Programs
3) By Nutritional Therapy: Protein Supplements, Nutritional Counseling, Dietary Modifications, Micronutrient Supplements
4) By Surgery: Surgical Interventions For Muscle Repair, Orthopedic Surgeries, Procedures For Underlying Conditions
5) By Gene Therapy: Gene Replacement Therapy, CRISPR-Based Approaches, RNA Interference Techniques 6) By Other Treatment Types: Complementary Therapies, Psychological Support, Assistive Devices
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., F. Hoffmann-La Roche Ltd., Roche Holding AG, Novartis AG, Sanofi, GlaxoSmithKline (GSK), Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals, Acceleron Pharma Inc., Biogen Inc., Santhera Pharmaceuticals Holding AG, Mitsubishi Tanabe Pharma, Nippon Shinyaku Co. Ltd. (NS Pharma, Inc.), Sarepta Therapeutics Inc., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Axogen, Inc., FibroGen Inc., Cytokinetics Incorporated, Italfarmaco S.p.A., Scholar Rock, Bellerophon Therapeutics, Akashi Therapeutics, aTyr Pharma, Metabolic Solutions Development Company, Synaptogenix, MyoKardia, Inc., MyoTherix Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Muscle Wasting Disorders Market Characteristics

3. Muscle Wasting Disorders Market Trends And Strategies

4. Muscle Wasting Disorders Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Muscle Wasting Disorders Growth Analysis And Strategic Analysis Framework

5.1. Global Muscle Wasting Disorders PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Muscle Wasting Disorders Market Growth Rate Analysis

5.4. Global Muscle Wasting Disorders Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Muscle Wasting Disorders Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Muscle Wasting Disorders Total Addressable Market (TAM)

6. Muscle Wasting Disorders Market Segmentation

6.1. Global Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Medications

Physical Therapy

Nutritional Therapy

Surgery

Gene Therapy

Other Treatment Types

6.2. Global Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Muscular Dystrophy

Amyotrophic Lateral Sclerosis (ALS)

Other Disorder Types

6.3. Global Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Rehab Centers

Specialty Clinics

Other End-Users

6.4. Global Muscle Wasting Disorders Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Anabolic Steroids

Hormonal Treatments

Anti-Inflammatory Drugs

Immunomodulatory Agents

6.5. Global Muscle Wasting Disorders Market, Sub-Segmentation Of Physical Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Resistance Training

Stretching Exercises

Aerobic Conditioning

Rehabilitation Programs

6.6. Global Muscle Wasting Disorders Market, Sub-Segmentation Of Nutritional Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Protein Supplements

Nutritional Counseling

Dietary Modifications

Micronutrient Supplements

6.7. Global Muscle Wasting Disorders Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Surgical Interventions For Muscle Repair

Orthopedic Surgeries

Procedures For Underlying Conditions

6.8. Global Muscle Wasting Disorders Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gene Replacement Therapy

CRISPR-Based Approaches

RNA Interference Techniques

6.9. Global Muscle Wasting Disorders Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Complementary Therapies

Psychological Support

Assistive Devices

7. Muscle Wasting Disorders Market Regional And Country Analysis

7.1. Global Muscle Wasting Disorders Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Muscle Wasting Disorders Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Muscle Wasting Disorders Market

8.1. Asia-Pacific Muscle Wasting Disorders Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Muscle Wasting Disorders Market

9.1. China Muscle Wasting Disorders Market Overview

9.2. China Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Muscle Wasting Disorders Market

10.1. India Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Muscle Wasting Disorders Market

11.1. Japan Muscle Wasting Disorders Market Overview

11.2. Japan Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Muscle Wasting Disorders Market

12.1. Australia Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Muscle Wasting Disorders Market

13.1. Indonesia Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Muscle Wasting Disorders Market

14.1. South Korea Muscle Wasting Disorders Market Overview

14.2. South Korea Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Muscle Wasting Disorders Market

15.1. Western Europe Muscle Wasting Disorders Market Overview

15.2. Western Europe Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Muscle Wasting Disorders Market

16.1. UK Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Muscle Wasting Disorders Market

17.1. Germany Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Muscle Wasting Disorders Market

18.1. France Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Muscle Wasting Disorders Market

19.1. Italy Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Muscle Wasting Disorders Market

20.1. Spain Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Muscle Wasting Disorders Market

21.1. Eastern Europe Muscle Wasting Disorders Market Overview

21.2. Eastern Europe Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Muscle Wasting Disorders Market

22.1. Russia Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Muscle Wasting Disorders Market

23.1. North America Muscle Wasting Disorders Market Overview

23.2. North America Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Muscle Wasting Disorders Market

24.1. USA Muscle Wasting Disorders Market Overview

24.2. USA Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Muscle Wasting Disorders Market

25.1. Canada Muscle Wasting Disorders Market Overview

25.2. Canada Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Muscle Wasting Disorders Market

26.1. South America Muscle Wasting Disorders Market Overview

26.2. South America Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Muscle Wasting Disorders Market

27.1. Brazil Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Muscle Wasting Disorders Market

28.1. Middle East Muscle Wasting Disorders Market Overview

28.2. Middle East Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Muscle Wasting Disorders Market

29.1. Africa Muscle Wasting Disorders Market Overview

29.2. Africa Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Muscle Wasting Disorders Market Competitive Landscape And Company Profiles

30.1. Muscle Wasting Disorders Market Competitive Landscape

30.2. Muscle Wasting Disorders Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Sanofi Overview, Products and Services, Strategy and Financial Analysis

31. Muscle Wasting Disorders Market Other Major And Innovative Companies

31.1. GlaxoSmithKline (GSK)

31.2. Eli Lilly and Company

31.3. Teva Pharmaceutical Industries Ltd.

31.4. Regeneron Pharmaceuticals

31.5. Acceleron Pharma Inc.

31.6. Biogen Inc.

31.7. Santhera Pharmaceuticals Holding AG

31.8. Mitsubishi Tanabe Pharma

31.9. Nippon Shinyaku Co. Ltd. (NS Pharma, Inc.)

31.10. Sarepta Therapeutics Inc.

31.11. PTC Therapeutics Inc.

31.12. Ionis Pharmaceuticals Inc.

31.13. Axogen, Inc.

31.14. FibroGen Inc.

31.15. Cytokinetics Incorporated

32. Global Muscle Wasting Disorders Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Muscle Wasting Disorders Market

34. Recent Developments In The Muscle Wasting Disorders Market

35. Muscle Wasting Disorders Market High Potential Countries, Segments and Strategies

35.1 Muscle Wasting Disorders Market In 2029 - Countries Offering Most New Opportunities

35.2 Muscle Wasting Disorders Market In 2029 - Segments Offering Most New Opportunities

35.3 Muscle Wasting Disorders Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Muscle Wasting Disorders Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Muscle Wasting Disorders Market, Sub-Segmentation Of Physical Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Muscle Wasting Disorders Market, Sub-Segmentation Of Nutritional Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Muscle Wasting Disorders Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Muscle Wasting Disorders Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Muscle Wasting Disorders Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Muscle Wasting Disorders Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Muscle Wasting Disorders Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Pfizer Inc. Financial Performance
  • Table 81: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 82: Roche Holding AG Financial Performance
  • Table 83: Novartis AG Financial Performance
  • Table 84: Sanofi Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Muscle Wasting Disorders Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Muscle Wasting Disorders Market, Sub-Segmentation Of Physical Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Muscle Wasting Disorders Market, Sub-Segmentation Of Nutritional Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Muscle Wasting Disorders Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Muscle Wasting Disorders Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Muscle Wasting Disorders Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Muscle Wasting Disorders Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Muscle Wasting Disorders Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Pfizer Inc. Financial Performance
  • Figure 81: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 82: Roche Holding AG Financial Performance
  • Figure 83: Novartis AG Financial Performance
  • Figure 84: Sanofi Financial Performance

$5.62 Billion Forecast for Liver Cancer Market by 2029, Backed by Demand and Innovation

Read More About $5.62 Billion Forecast for Liver Cancer Market by 2029, Backed by Demand and Innovation

Lupus Nephritis Market Valuation Expected To Reach $2.78 Billion By 2029, Growing At A Rate Of 7.5%

Read More About Lupus Nephritis Market Valuation Expected To Reach $2.78 Billion By 2029, Growing At A Rate Of 7.5%

Strong CAGR to Propel in the Malignant Mesothelioma Market and Beyond upto $3.32 Billion by 2029

Read More About Strong CAGR to Propel in the Malignant Mesothelioma Market and Beyond upto $3.32 Billion by 2029

Malignant Pleural Effusion Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

Read More About Malignant Pleural Effusion Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Read More About Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Read More About Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Review key data-driven trends shaping the global data storage market in 2025.

Read More About Review key data-driven trends shaping the global data storage market in 2025.

Wheel Stud Global Market Report 2025 – By Product (Screw-In Wheel Studs, Press-In Wheel studs, Welded-In Wheel Studs), By Distribution Channel (Original Equipment Manufacturer (OEM), Aftermarket), By Application (Aerospa...

View Report

Stationary Catalytic Systems Global Market Report 2025 – By Technology (Selective Catalytic Reduction, Oxidation Catalyst), By Pollutant Type (Nox (Nitrogen Oxides), CO (Carbon Monoxide) Hydrocarbons, HAP (Hazardous Air ...

View Report

Coordinate Measuring Machine Global Market Report 2025 – By Type (Fixed CMM, Portable CMM ), By Application (Inspection, Reverse Engineering), By Industry (Automotive, Aerospace, Heavy Machinery, Energy and Power, Electr...

View Report

Automotive Shielding Global Market Report 2025 – By Shielding Type (Heat Shielding, EMI Shielding), By Material Type (Metallic, Non-Metallic), By Vehicle Type (Passenger Car, Light Commercial Vehicle, Heavy Commercial Ve...

View Report

RF Signal Chain Components Global Market Report 2025 – By Product (Amplifiers, Voltage-Controlled Oscillators, Power Dividers, Mixers, Filters, Switches, Attenuators, Diplexers, Duplexers, Couplers ), By Material Type (G...

View Report

Alzheimer's Drugs Global Market Report 2025 – By Drugs (Donepezil, Rivastigmine, Galantamine, Memantine ), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy ), By Application (Early To Moderate...

View Report

Aerospace Helmet Mounted Display Global Market Report 2025 – By Component (Processor And Memory, Controller, Sensor, Display, Lens, Other Components ), By Technology (Augmented Reality, Virtual Reality ), By Application ...

View Report

Microdisplay Global Market Report 2025 – By Product (Near-To-Eye (NTE) Devices, Head-Up Displays (HUDs), Projectors, Other Products), By Brightness (Less Than 500 Nits, 500–1,000 Nits, More Than 1,000 Nits), By Resolutio...

View Report

Frequently Asked Questions

Muscle wasting disorders, or muscle atrophy or muscle wasting, refer to a condition characterized by a diverse group of conditions that cause the progressive loss of muscle mass and strength. This can occur as a result of various factors, including disuse, aging, malnutrition, neurodegenerative diseases, and certain medical conditions. For further insights on this market, request a sample here

The market major growth driver - Sedentary Lifestyle Trends Fueling Growth In The Muscle Wasting Disorders Market. For further insights on this market, request a sample here

The muscle wasting disorders market size has grown rapidly in recent years. It will grow from $15.06 billion in 2024 to $17.49 billion in 2025 at a compound annual growth rate (CAGR) of 16.1%. The growth in the historic period can be attributed to increasing aging population, rising incidence of chronic diseases, advancements in research and development, increased awareness of early diagnosis, emerging therapeutic approaches. The muscle wasting disorders market size is expected to see rapid growth in the next few years. It will grow to " $29.52 billion in 2029 at a compound annual growth rate (CAGR) of 14.0%. The growth in the forecast period can be attributed to regulatory support, patient advocacy initiatives, healthcare infrastructure development, globalization of clinical trials, personalized medicine approaches. Major trends in the forecast period include telemedicine adoption, technological advancements in diagnostics, product innovation, collaborations and partnerships, advancements in therapeutics, research on molecular mechanisms, biopharmaceutical innovation. For further insights on this market, request a sample here

The muscle wasting disordersmarket covered in this report is segmented –
1) By Treatment Type: Medications; Physical Therapy; Nutritional Therapy; Surgery; Gene Therapy; Other Treatment Types
2) By Disorder Type: Muscular Dystrophy; Amyotrophic Lateral Sclerosis (ALS); Other Disorder Types
3) By End-User: Hospitals; Rehab Centers; Specialty Clinics; Other End-Users Subsegments:
1) By Medications: Anabolic Steroids; Hormonal Treatments; Anti-Inflammatory Drugs; Immunomodulatory Agents
2) By Physical Therapy: Resistance Training; Stretching Exercises; Aerobic Conditioning; Rehabilitation Programs
3) By Nutritional Therapy: Protein Supplements; Nutritional Counseling; Dietary Modifications; Micronutrient Supplements
4) By Surgery: Surgical Interventions For Muscle Repair; Orthopedic Surgeries; Procedures For Underlying Conditions
5) By Gene Therapy: Gene Replacement Therapy; CRISPR-Based Approaches; RNA Interference Techniques
6) By Other Treatment Types: Complementary Therapies; Psychological Support; Assistive Devices For further insights on this market, request a sample here

North America was the largest region in the muscle wasting disorder market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the muscle wasting disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the muscle wasting disorders market report are Pfizer Inc., F. Hoffmann-La Roche Ltd., Roche Holding AG, Novartis AG, Sanofi, GlaxoSmithKline (GSK), Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals, Acceleron Pharma Inc., Biogen Inc., Santhera Pharmaceuticals Holding AG, Mitsubishi Tanabe Pharma, Nippon Shinyaku Co. Ltd. (NS Pharma, Inc.), Sarepta Therapeutics Inc., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Axogen, Inc., FibroGen Inc., Cytokinetics Incorporated, Italfarmaco S.p.A., Scholar Rock, Bellerophon Therapeutics, Akashi Therapeutics, aTyr Pharma, Metabolic Solutions Development Company, Synaptogenix, MyoKardia, Inc., MyoTherix Inc.. For further insights on this market, request a sample here.

Major trends in this market include Innovative Advancements In The Muscle Wasting Disorders Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Muscle Wasting Disorders Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top